vs
Side-by-side financial comparison of Bio-Techne (TECH) and Vroom, Inc. (VRM). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $235.9M, roughly 1.3× Vroom, Inc.). Bio-Techne runs the higher net margin — 12.8% vs -59.8%, a 72.7% gap on every dollar of revenue. On growth, Vroom, Inc. posted the faster year-over-year revenue change (12.9% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -49.5%).
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
Vroom, Inc. is a parent company of United Auto Credit Corporation (UACC) and CarStory. Previously, Vroom was a used car retailer and e-commerce company that let consumers buy, sell, and finance cars online. Vroom ceased e-commerce automotive sales operations on January 22, 2024.
TECH vs VRM — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2023
| Metric | | |
|---|---|---|
| Revenue | $295.9M | $235.9M |
| Net Profit | $38.0M | $-141.1M |
| Gross Margin | 64.6% | 12.3% |
| Operating Margin | 18.4% | -11.5% |
| Net Margin | 12.8% | -59.8% |
| Revenue YoY | -6.4% | 12.9% |
| Net Profit YoY | 68.3% | -669.8% |
| EPS (diluted) | $0.24 | $-80.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $295.9M | — | ||
| Q2 25 | $317.0M | — | ||
| Q1 25 | $316.2M | — | ||
| Q4 24 | $297.0M | — | ||
| Q3 24 | $289.5M | — | ||
| Q2 24 | $306.1M | — | ||
| Q1 24 | $303.4M | — | ||
| Q4 23 | $272.6M | $235.9M |
| Q4 25 | $38.0M | — | ||
| Q2 25 | $-17.7M | — | ||
| Q1 25 | $22.6M | — | ||
| Q4 24 | $34.9M | — | ||
| Q3 24 | $33.6M | — | ||
| Q2 24 | $40.6M | — | ||
| Q1 24 | $49.1M | — | ||
| Q4 23 | $27.5M | $-141.1M |
| Q4 25 | 64.6% | — | ||
| Q2 25 | 62.7% | — | ||
| Q1 25 | 67.9% | — | ||
| Q4 24 | 65.3% | — | ||
| Q3 24 | 63.2% | — | ||
| Q2 24 | 66.4% | — | ||
| Q1 24 | 67.4% | — | ||
| Q4 23 | 64.8% | 12.3% |
| Q4 25 | 18.4% | — | ||
| Q2 25 | -7.5% | — | ||
| Q1 25 | 12.2% | — | ||
| Q4 24 | 16.0% | — | ||
| Q3 24 | 13.8% | — | ||
| Q2 24 | 15.0% | — | ||
| Q1 24 | 22.1% | — | ||
| Q4 23 | 13.9% | -11.5% |
| Q4 25 | 12.8% | — | ||
| Q2 25 | -5.6% | — | ||
| Q1 25 | 7.1% | — | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 11.6% | — | ||
| Q2 24 | 13.3% | — | ||
| Q1 24 | 16.2% | — | ||
| Q4 23 | 10.1% | -59.8% |
| Q4 25 | $0.24 | — | ||
| Q2 25 | $-0.11 | — | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | $0.22 | — | ||
| Q3 24 | $0.21 | — | ||
| Q2 24 | $0.26 | — | ||
| Q1 24 | $0.31 | — | ||
| Q4 23 | $0.17 | $-80.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $172.9M | $135.6M |
| Total DebtLower is stronger | $260.0M | $454.2M |
| Stockholders' EquityBook value | $2.0B | $127.7M |
| Total Assets | $2.5B | $1.5B |
| Debt / EquityLower = less leverage | 0.13× | 3.56× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $172.9M | — | ||
| Q2 25 | $162.2M | — | ||
| Q1 25 | $140.7M | — | ||
| Q4 24 | $177.5M | — | ||
| Q3 24 | $187.5M | — | ||
| Q2 24 | $152.9M | — | ||
| Q1 24 | $145.3M | — | ||
| Q4 23 | $135.7M | $135.6M |
| Q4 25 | $260.0M | — | ||
| Q2 25 | $346.0M | — | ||
| Q1 25 | $330.0M | — | ||
| Q4 24 | $300.0M | — | ||
| Q3 24 | $300.0M | — | ||
| Q2 24 | $319.0M | — | ||
| Q1 24 | $389.0M | — | ||
| Q4 23 | $447.0M | $454.2M |
| Q4 25 | $2.0B | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — | ||
| Q1 24 | $2.0B | — | ||
| Q4 23 | $2.0B | $127.7M |
| Q4 25 | $2.5B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.7B | — | ||
| Q3 24 | $2.7B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — | ||
| Q4 23 | $2.7B | $1.5B |
| Q4 25 | 0.13× | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.19× | — | ||
| Q4 23 | 0.23× | 3.56× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-108.1M |
| Free Cash FlowOCF − Capex | — | $-108.8M |
| FCF MarginFCF / Revenue | — | -46.1% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-536.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q2 25 | $98.2M | — | ||
| Q1 25 | $41.1M | — | ||
| Q4 24 | $84.3M | — | ||
| Q3 24 | $63.9M | — | ||
| Q2 24 | $75.5M | — | ||
| Q1 24 | $81.0M | — | ||
| Q4 23 | $83.1M | $-108.1M |
| Q4 25 | — | — | ||
| Q2 25 | $93.3M | — | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $77.5M | — | ||
| Q3 24 | $54.7M | — | ||
| Q2 24 | $57.5M | — | ||
| Q1 24 | $64.5M | — | ||
| Q4 23 | $68.3M | $-108.8M |
| Q4 25 | — | — | ||
| Q2 25 | 29.4% | — | ||
| Q1 25 | 9.8% | — | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 18.9% | — | ||
| Q2 24 | 18.8% | — | ||
| Q1 24 | 21.3% | — | ||
| Q4 23 | 25.0% | -46.1% |
| Q4 25 | — | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 5.9% | — | ||
| Q1 24 | 5.4% | — | ||
| Q4 23 | 5.5% | 0.3% |
| Q4 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.82× | — | ||
| Q4 24 | 2.42× | — | ||
| Q3 24 | 1.90× | — | ||
| Q2 24 | 1.86× | — | ||
| Q1 24 | 1.65× | — | ||
| Q4 23 | 3.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
VRM
Segment breakdown not available.
